RESEARCH PEPTIDE
Tesamorelin 10 mg
Tesamorelin 10 mg
Tesamorelin is a GHRH analogue studied for endogenous growth-hormone pulsatility and downstream IGF-1 signalling.
Quality documentation
Certificate of Analysis Available
View the available testing documentation for Tesamorelin 10 mg.
IDR 2.999.000
- Product
- Tesamorelin
- Strength
- 10 mg
- Category
- Research Peptides
- Purity
- ≥99.6% PURITY
- Use
- Laboratory and scientific research only
- Price
- IDR 2.999.000
The power of GHRH-pathway research.
Tesamorelin is a GHRH analogue studied for endogenous growth-hormone pulsatility and downstream IGF-1 signalling.
Research context
Human endocrine studies examine tesamorelin through GHRH signalling, pulsatile growth-hormone release, and downstream IGF-1 response. This profile supports controlled endocrine research without implying general fat-loss, recovery, or anti-ageing outcomes.
Research interests
- GHRH receptor signalling
- Growth-hormone pulsatility
- Downstream IGF-1 research
Explore further
Related research products
Research Peptides≥99.6% PURITY10 mg
AOD-9604 is a modified C-terminal growth-hormone fragment studied in preclinical lipid-metabolism, fat-oxidation, and adipose-signalling models.
≥99.6% PURITY
IDR 3.499.000
Research Peptides≥99.6% PURITY10 mg
BPC-157 is studied in preclinical models of tendon-fibroblast migration, FAK–paxillin activation, and tissue-repair signalling.
≥99.6% PURITY
IDR 1.199.000
Research Peptides≥99.6% PURITY5 mg
CJC-1295 is studied within growth hormone-releasing hormone research for its influence on GH and IGF-1 signalling.
≥99.6% PURITY
IDR 1.399.000
Research Peptides≥99.6% PURITY10 mg
DSIP is an exploratory neuropeptide studied at the intersection of slow-wave EEG activity, sleep signalling, and neuroendocrine regulation.
≥99.6% PURITY
IDR 2.199.000